The Ovarian-Adnexal Reporting and Data System (O-RADS) is an evidence-based clinical support system for ovarian and adnexal lesion assessment in women of average risk. The system has both US and MRI components with separate but complementary lexicons and assessment categories to assign the risk of malignancy. US is an appropriate initial imaging modality, and O-RADS US can accurately help to characterize most adnexal lesions. MRI is a valuable adjunct imaging tool to US, and O-RADS MRI can help to both confirm a benign diagnosis and accurately stratify lesions that are at risk for malignancy. This article will review the O-RADS US and MRI systems, highlight their similarities and differences, and provide an overview of the interplay between the systems. When used together, the O-RADS US and MRI systems can help to accurately diagnose benign lesions, assess the risk of malignancy in lesions suspicious for malignancy, and triage patients for optimal management.

中文翻译：

---

卵巢附件报告和数据系统 US 和卵巢附件报告和数据系统 MRI 在附件病变评估中的作用。


卵巢附件报告和数据系统 (O-RADS) 是一个循证临床支持系统，用于评估平均风险女性的卵巢和附件病变。该系统具有 US 和 MRI 组件，具有独立但互补的词典和评估类别来分配恶性肿瘤风险。 US 是一种合适的初始成像方式，O-RADS US 可以准确地帮助描述大多数附件病变的特征。 MRI 对美国来说是一种有价值的辅助成像工具，O-RADS MRI 可以帮助确认良性诊断并准确对有恶性肿瘤风险的病变进行分层。本文将回顾 O-RADS US 和 MRI 系统，强调它们的异同，并概述系统之间的相互作用。当结合使用时，O-RADS US 和 MRI 系统可以帮助准确诊断良性病变，评估可疑恶性肿瘤的恶性风险，并对患者进行分类以实现最佳治疗。